SIGA TECHNOLOGIES INC (SIGA) research

SIGA TECHNOLOGIES INC
ShareXLinkedInReddit
Sector
Pharmaceuticals
Last price
$3.25
As of

SIGA TECHNOLOGIES INC (SIGA): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-06.

As of . Source: SEC EDGAR filings for SIGA. Method and limitations.

SHARE THIS CARD

Share the SIGA intelligence card

A branded snapshot of SIGA: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion SIGA intelligence card preview
Post to X
LIVE TERMINAL

See SIGA live in the terminal

Track SIGA's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live SIGA terminal, free

Active signals for SIGA

FREE, NO ACCOUNT

Every signal on SIGA, as it fires

You are seeing 5 of 9 signals recorded on SIGA since 2026-07-24.

The five above landed across 2 days. The other 4 were recorded on 1 other days. 9 of the 9 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in SIGA (2026Q2)

Manager / securityMarket value% portfolioQoQ
MILLENNIUM MANAGEMENT LLCCUSIP 826917106 · 2026Q2$2.1M0.00%,
CITADEL ADVISORS LLCCUSIP 826917106 · 2026Q2$2M0.00%,
RENAISSANCE TECHNOLOGIES LLCCUSIP 826917106 · 2026Q2$1.5M0.00%,
TWO SIGMA INVESTMENTS, LPCUSIP 826917106 · 2026Q2$1.3M0.00%,
D. E. Shaw & Co., Inc.CUSIP 826917106 · 2026Q2$964K0.00%,
Point72 Asset Management, L.P.CUSIP 826917106 · 2026Q2$212K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, SIGA

SIGA against its peers

SIGA's operating margin of 25.1% ranks in the 92nd percentile of 17 Pharmaceuticals sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.

MetricSIGAPeer medianPercentilen
Revenue FY94.6M USD403M USD4319
Gross marginn/a59.3%n/a5
Operating margin25.1%8.5%9217
Net margin24.6%0.2%9217
Return on equity11.7%-21.5%7021
P / E10.2x13.7x178

Peers (24): FULC, BIOA, AVIR, COLL, PLRX, ACRS, ESPR, PCRX, AMPH, ALMS, ANRO, PAHC, INVA, OMER, XERS, ANIP, NUVB, TRVI, BHC, OCUL, NKTR, SUPN, HRMY, GPCR. Left out: ACB (period gap). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (SIGA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more SIGA signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to SIGAand get the insider, 13F, options, and confluence read in one view.

Open the live SIGA terminal, free